{"id":"clm_504246A9C0D6","entity":"abbott-laboratories","predicate":"operating_income","value":"8,362,000,000 United States dollar","value_json":{"fy":2022,"accn":"0001628280-23-004026","form":"10-K","filed":"2023-02-17","concept":"us-gaap:OperatingIncomeLoss"},"valid_from":"2022-12-31","valid_to":"2023-12-31","published":"2023-02-17","recorded":"2026-11-08","citation":{"plain":"AsOf. \"Abbott Laboratories operating income: 8,362,000,000 United States dollar\", as of 2022-12-31 (until 2023-12-31). Claim clm_504246A9C0D6, https://asof.is/claim/clm_504246A9C0D6, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/1800/000162828023004026/0001628280-23-004026-index.htm.","url":"https://asof.is/claim/clm_504246A9C0D6","accessed":"2026-11-09"},"confidence":0.95,"status":"superseded","assertable":true,"superseded_by":"clm_492DDC48ED34","supersedes":["clm_92EA1FC35D1F"],"first_seen_at":"2026-11-08T16:56:05.679592+00:00","updated_at":"2026-11-08T16:56:16.878388+00:00","sources":[{"url":"https://www.sec.gov/Archives/edgar/data/1800/000162828023004026/0001628280-23-004026-index.htm","tier":"primary","publisher":"SEC EDGAR 10-K FY2022","published_at":"2023-02-17T00:00:00+00:00"}],"evidence":{"by":"sec-filing","on":"2026-11-08","fact":"us-gaap:OperatingIncomeLoss in 10-K FY2022, filed 2023-02-17"},"legend":{"dates":"valid_from: when the claim took effect (a period figure: the day its period closed). published: the earliest day a source on the record published it (a filing's filing date, a post's date; null when no source carries one). recorded: the day AsOf first held it. A figure can take effect weeks before it is published.","citation":"citation: how to cite the row (plain: one sentence with the value, its as-of date, the claim id and URL, the day answered and the primary source; url: the claim page; accessed: the day answered). APA and BibTeX forms are on the claim page.","why_not":{},"checked_by":{"sec-filing":"parsed from the SEC filing"}}}